Comprehensive Analysis of Glycolytic Enzymes as Therapeutic Targets in the Treatment of Glioblastoma

• Morgane Sanzey,

  Affiliation NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health (L.I.H.), Luxembourg, Luxembourg

  ⨯
• Siti Aminah Abdul Rahim,

  Affiliation NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health (L.I.H.), Luxembourg, Luxembourg

  ⨯
• Anais Oudin,

  Affiliation NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health (L.I.H.), Luxembourg, Luxembourg

  ⨯
• Anne Dirkse,

  Affiliation NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health (L.I.H.), Luxembourg, Luxembourg

  ⨯
• Tony Kaoma,

  Affiliation Genomics Research Unit, Luxembourg Institute of Health (L.I.H.), Luxembourg, Luxembourg

  ⨯
• Laurent Vallar,

  Affiliation Genomics Research Unit, Luxembourg Institute of Health (L.I.H.), Luxembourg, Luxembourg

  ⨯
• Christel Herold-Mende,

  Affiliation Experimental Neurosurgery, Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany

  ⨯
• Rolf Bjerkvig,

  Affiliations NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health (L.I.H.), Luxembourg, Luxembourg, NorLux Neuro-Oncology Laboratory, Department of Biomedicine, University of Bergen, Bergen, Norway, KG Jebsen Brain Tumour Research Center, Department of Biomedicine, University of Bergen, Bergen, Norway

  ⨯
• Anna Golebiewska,

  Affiliation NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health (L.I.H.), Luxembourg, Luxembourg

  ⨯
• Simone P. Niclou

  * E-mail: simone.niclou@lih.lu

  Affiliations NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health (L.I.H.), Luxembourg, Luxembourg, KG Jebsen Brain Tumour Research Center, Department of Biomedicine, University of Bergen, Bergen, Norway

  ⨯